Products |

EnligHTN renal denervation system

Related Content

Clinical Data Demonstrates Reduction in Blood Pressure with Recor Medical’sUltrasound Renal Denervation System
News | Renal Denervation
Clinical Data Demonstrates Reduction in Blood Pressure with Recor Medical’sUltrasound Renal Denervation System

Oct. 30, 2025 — Recor Medical and its parent company, Otsuka Medical Devices presented the results from two clinical ...

Home November 03, 2025
Home
Medtronic Hybrid Ablation
Feature | Renal Denervation | Kyle Hardner
New Guidelines Support Renal Denervation for Uncontrolled Hypertension

Hypertension remains the leading modifiable driver of cardiovascular disease and premature death.1 Even with multiple ...

Home October 02, 2025
Home
First Patient Treated in Medtronic Multi-Organ SPYRAL GEMINI Pilot Study
News | Renal Denervation
First Patient Treated in Medtronic Multi-Organ SPYRAL GEMINI Pilot Study

July 7, 2025 — Medtronic announced that it has treated the first patient in its SPYRAL GEMINI Pilot program (including ...

Home July 07, 2025
Home
Medtronic
News | Renal Denervation
Medtronic Presents New Data, Clinical Milestones

At the Cardiovascular Research Technologies (CRT) 2025 conference in Washington, D.C., Medtronic presented new data and ...

Home March 10, 2025
Home
News | Renal Denervation
Medtronic Receives CMS National Coverage Analysis for Renal Denervation System

Jan. 13, 2025 — Medtronic recently announced that the Centers for Medicare & Medicaid Services (CMS) is opening a ...

Home January 27, 2025
Home
News | Renal Denervation
Medtronic Receives CMS National Coverage Analysis for Renal Denervation System

Jan. 13, 2025 — Medtronic plc recently announced that the Centers for Medicare & Medicaid Services (CMS) is opening a ...

Home January 14, 2025
Home
Approval is the culmination of ten years of clinical research and development of the Medtronic renal denervation technology
News | Renal Denervation
Medtronic Announces FDA Approval of Minimally Invasive Device to Treat Hypertension

November 20, 2023 — Medtronic plc, a global leader in healthcare technology, announced that the United States Food and ...

Home November 20, 2023
Home
The Society for Cardiovascular Angiography & Interventions (SCAI) has released a position statement on Renal Denervation (RDN), emphasizing patient selection, optimal techniques, competence, training, and institutional recommendations
News | Renal Denervation
New SCAI Position Statement Highlights the Role of Renal Denervation in Hypertension Treatment

August 21, 2023 — The Society for Cardiovascular Angiography & Interventions (SCAI) has released a position statement on ...

Home August 21, 2023
Home
Primary Results from RADIANCE II Trial Published in JAMA and Results of Pooled Analysis from Three RADIANCE Studies Published in JAMA Cardiology
News | Renal Denervation
ReCor Medical Announces Two Concurrent JAMA Network Publications of Study Results on the Paradise Ultrasound Renal Denervation System for the Treatment of Hypertension

March 2, 2023 — ReCor Medical, Inc. and its parent company, Otsuka Medical Devices Co., Ltd. announced that primary ...

Home March 02, 2023
Home
SoniVie, an Israeli company developing the Therapeutic Intra-Vascular Ultrasound (TIVUS) System to treat a variety of hypertensive disorders, announced that it has been granted Breakthrough Device Designation from the U.S. Food and Drug Administration (FDA). The  TIVUS System for renal artery denervation treats resistant hypertension, which is defined as blood pressure that remains above 140/90 mmHg despite use of three antihypertensive medications of different classes at the best tolerated doses.
News | Renal Denervation
FDA Grants Breakthrough Device Designation for the TIVUS Renal Artery Denervation System

December 9, 2020 — SoniVie, an Israeli company developing the Therapeutic Intra-Vascular Ultrasound (TIVUS) System to ...

Home December 09, 2020
Home
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now